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Table 1
PCA with varimax rotation for 11 different sites on CE-MRI, component loading*
Anatomical sites of synovitis on CE-MRI Components
1 2 3 4
Adjacent to posterior cruciate ligament site 0.762
Suprapatellar site 0.762
Intercondylar site (at surface of Hoffa's
fat pad)
0.720
Lateral parameniscal site 0.461 0.454
Medial parapatellar site 0.821
Lateral parapatellar site 0.791
Baker Cyst 0.635
Adjacent to the anterior cruciate ligament 0.806
Medial parameniscal site 0.746
Loose Body 0.832
Infra patellar site -0.707
% variance explained 23% 20% 12% 12%
* Note: only loadings >0.4 are displayed
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conformation and release inmedia by the different tissueswas evaluated
using Western Blot (WB) and ELISA, respectively. In parallel, proteins
were extracted from frozen joint tissues to assess the in situ production
and conformation of visfatin/NAMPT by WB. NAMPT enzymatic activity
was also assessed in OA synovium using Cyclex colorimetric assay.
Primary cultures of mouse chondrocytes and osteoblasts were stimu-
latedwith recombinant visfatin/NAMPT (5 mg/mL) for 24h. To determine
in vitro the role of the NAMPT activity, cells were pretreated or not 4h
before visfatin/NAMPT stimulation with APO866 (10nM), a pharmaco-
logic inhibitor of NAMPT activity (1). Effects of stimulation on IL-6, IL-8/
Kc, MCP-1, VEGF and TGFb expression, and on IL-6, IL-8/Kc and MCP-1
release were examined by quantitative RT-PCR and ELISA, respectively.
Results: All human OA joint tissues released visfatin/NAMPT (syno-
vium: 529 356, cartilage: 237 380, subchondral bone: 195 92 ng/g
tissue) with higher level for the synovium compared to cartilage and
subchondral bone (p<0.01). In tissular explants and conditionnated
media, visfatin/NAMPT was found as a homodimer, corresponding to
the enzymatically active conformation. Moreover, NAMPT activity was
identiﬁed ex vivo in synovium and characterized by a reaction velocity
at 1.38E-3  8E-4 min-1 (n¼3). Visfatin/NAMPT signiﬁcantly induced IL-
6, IL-8/Kc and MCP-1 gene expressions and protein productions by
chondrocytes and osteoblasts (n[6) (Table). Nampt activity inhibi-
tion by APO866 decreased pro-inﬂammatory cytokines expression
atmRNA level (up to 94 % of inhibition) as well as at protein level (up
to 63 % of inhibition) and was especially efﬁcient in chondrocytes
(Table). VEGF and TGFb expression were unchanged upon stimulation,
suggesting that visfatin/NAMPT has selective properties.
Conclusions:Visfatin/NAMPT is releasedbyall OA tissuesunder a dimeric
enzymatically active conformation and mostly by the synovium which
displays a detectable NAMPT activity. The NAMPT activity of visfatin is
involved in chondrocytes and osteoblasts activation, suggesting that tar-
geting its enzymatic activity with a compound like APO866 (being tested
in hematological malignancies) may be a new therapeutic approach.Gene expression Protein production
IL-6 Kc/IL-8 MCP-1 IL-6 Kc/IL-8 MCP-1
Chonodrocytes
(n ¼ 6)
Fold induction after visfatin/NAMPT
stimulation (Mean  SEM), p-value
10.6  3
(p ¼ 0.015)
4.9  1.3
(p ¼ 0.015)
2.5  0.4
(p ¼ 0.03)
5.8  5
(p ¼ 0.016)
29.7  33
(p ¼ 0.015)
10.5  2
(p ¼ 0.016)
Mean % of inhibition by APO866, p-value 94 %
(p ¼ 0.015)
83 %
(p ¼ 0.015)
62 %
(p ¼ 0.015)
63 %
(p ¼ 0.016)
57 %
(p ¼ 0.031)
54 %
(p ¼ 0.016)
Osteoblasts
(n ¼ 6)
Fold induction after visfatin/NAMPT
stimulation (Mean  SEM), p-value
296  59
(p ¼ 0.031)
262  96
(p ¼ 0.016)
161  78
(p ¼ 0.016)
115  46
(p ¼ 0.016)
164  71
(p ¼ 0.016)
22  7
(p ¼ 0.031)
Mean SEM % of inhibition by APO866 63 %
(p ¼ 0.031)
86 %
(p ¼ 0.016)
84 %
(p ¼ 0.047)
31 %
(p ¼ 0.031)
34 %
(p ¼ 0.08)
41 %
(p ¼ 0.06)16
DIFFERENT PATTERNS OF SYNOVITIS AS SEEN ON CE-MRI IN
PATIENTS WITH KNEE OSTEOARTHRITIS
B. de Lange-Brokaar y, A. Ioan-Facsinay y, E. Yusuf y, W. Visser y, H.
Kroon y, G. van Osch z, A.-M. Zuurmond x, V. Stojanovic-Susulic k, J.
Bloem y, R. Nelissen y, T. Huizinga y, M. Kloppenburg y. y LUMC, Leiden,
Netherlands; z Erasmus MC, Rotterdam, Netherlands; x TNO, Leiden,
Netherlands; k Janssen Res. & Dev., LLC, Spring House, PA, USAPurpose: Synovitis is prevalent in knee OA and is an important deter-
minant of pain. To better understand the nature of synovitis and its
association with pain we investigated patterns of synovitis on contrast
enhanced (CE) MRI and its relation to pain.
Methods:43patients (mean (SD)age60(21)years, 63%woman,BMI30(5)
kg/mm2, median (IQR) Kellgren-Lawrence score 3 (2-4)) with symptom-
atic knee OA attending the rheumatology or orthopaedic outpatient clinic
were included. 22 patients underwent arthroscopy and 21 arthroplasty.
Sagittal and axial T1-weighted CE MRI images (3T) were used to semi-
quantitatively score synovitis at 11 sites (total range 0-22) according to
Guermazi et al. (Ann RheumDis 2011). Self-reported painwas assessed by
visual analogue scale (VAS, 0-100), knee injuryand osteoarthritis outcome
score (KOOS (subscale pain),0-100) and measure of intermittent and
constant osteoarthritis pain (ICOAP, intermittent pain (0-100), constant
pain (0-100)). Principal component analysis (PCA) with varimax rotation
and Keiser Normalizationwas used to investigate patterns of synovitis for
all patients. A factor was said to load signiﬁcantly on a component whenloading exceeded 0.4. Subsequently, different patterns were associated
with pain measures in linear regression analysis adjusted for age, sex and
BMI, using SPSS 20.0. Log transformations were used when appropriate.
Results: A mild synovitis was observed (mean (SD) 8.0 (3.7)). Mean (SD)
KOOS pain was 49.6 (23.6) and ICOAP intermittent pain 42.0 (21.8).
Median (IQR) VASwas 57.0 (37-68) and ICOAP constant pain 35.0 (20-55).
PCA resulted in extraction of 4 components (Eigen value > 1), explaining
67% of variance (Table 1). Component 2 associated with KOOS pain and
ICOAP constant pain, not with VAS and ICOAP intermittent pain.
Component 3 associatedwithVASpain andnotwith other painmeasures.
Component 1 and 4 did not associate with any of the pain measures.
Conclusion: Different patterns of synovitis in knee OA were observed.
Results suggest that pain depends on synovitis pattern.17
HIGH SERUM-CHOLESTEROL LEVELS BY EITHER LOW DENSITY
LIPOPROTEIN RECEPTOR DEFICIENCY OR A CHOLESTEROL-RICH
DIET RESULTS IN SYNOVIAL ACTIVATION AND OSTEOPHYTE
FORMATION DURING EXPERIMENTAL OSTEOARTHRITIS
W. de Munter, A.W. Slöetjes, B. Walgreen, M.M. Helsen, W.B. van den
Berg, P.L. van Lent. Radboud Univ. Nijmegen Med. Ctr., Nijmegen,
Netherlands
Purpose: Recently, we have shown that synovial activation plays an
important role in etiopathology of osteoarthritis (OA). Synovial
macrophages are involved in cartilage damage and are crucial for
osteophyte formation in experimental OAmodels. Increased cholesterol
levels have been correlated to OA pathology suggesting a metabolic
mechanism. Atherosclerotic studies show that scavenger receptors on
macrophages are capable of taking up oxidized low density lipoprotein
(oxLDL), resulting in increased inﬂammatory properties of the macro-
phage. Accumulated LDL can be oxidized in an inﬂammatory milieu
such as OA, possibly resulting in oxLDL uptake of synovial macrophages.
We investigated whether increased LDL levels could lead tomore severe
OA pathology in experimental induced OA.
Methods: LDL receptor deﬁcient (LDLr-/-) mice and their wild type (WT)
controls received either a cholesterol-rich or control diet for 120 days
(n¼10 mice per group). Experimental OAwas induced by intra-articular
injection of collagenase on day 84 and 86. 36 days after OA induction,
mice were sacriﬁced and total knee joints (for histological analysis) and
serum were collected. Cartilage damage, synovial thickening and
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Osteophyte formation was measured using digital image analysis. Bone
marrow derived cells were differentiated into macrophages and pre-
incubated with oxLDL or LDL for 24 hours, after which they were
stimulatedwith the endogenous toll-like receptor 4 ligand S100A8. RNA
was analyzed for gene expression. Data are depicted as mean  SEM.
Results:WT mice receiving a normal diet developed moderate cartilage
destruction (6.1  1.5), synovial thickening (1.4  0.2) and osteophyte
formation (32.4mm214.6). SerumLDL levelswere signiﬁcantly higher in
LDLr-/-micecompared toWTmice (7.33mmol/L0.46and0.54mmol/L
0.04 respectively; p<0.05), which was additionally increased by
a cholesterol-rich diet (38.73 mmol/L  3.11; p<0.0001). Despite differ-
ences in serum LDL levels, no signiﬁcant differences between the four
groups were found regarding synovial thickening and cartilage destruc-
tion. Expression of S100A8 by the synovial lining, however, was increased
after receiving a cholesterol-rich diet, suggesting synovial activation.
Furthermore, a cholesterol-rich diet increased ApoB accumulation in
synovial lining macrophages of LDLr-/- mice. Interestingly, at the tibial
plateau, LDLr-/- mice showed almost a fourfold increase of osteophyte
formation compared to WT mice (206.3 mm2  36.3; p<0.05). When
receivingacholesterol-richdiet, osteophyte formationat the lateral sideof
the tibialplateau inLDLr-/-mice further increased from107.0mm249.3 to
309.4 mm2  41.7 (p<0.05). In vitro stimulation of oxLDL-laden macro-
phages with S100A8 showed a signiﬁcant decrease of anti-inﬂammatory
cytokine IL-10 expression and an increase of BMP6 expression compared
to macrophages that were not pre-incubated with oxLDL.
Conclusions: Increased serum cholesterol levels by either LDL receptor
deﬁciency or as a result of a cholesterol-rich diet stimulate oxLDL uptake
by synovial lining macrophages, resulting in synovial activation. In
accordance with in vitro data, synovial activation elicited by oxLDL leads
to an inﬂammatorymilieu reﬂected by increased S100A8 levels andmay
stimulate osteophyte formation at the margins of the tibial plateau.
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THE TRANSIENT RECEPTOR POTENTIAL VANILLOID 4 ION CHANNEL
REGULATES THE BIOSYNTHETIC RESPONSE OF CHONDROCYTES TO
DYNAMIC LOADING
C.J. O'Conor y,z, H.C. Beneﬁeld y, W. Liedtke y, F. Guilak y. yDuke Univ.,
Durham, NC, USA; zUniv. of North Carolina, Chapel Hill, NC, USA
Purpose: Mechanical factors play an important role in modulating the
metabolic and functional properties of normal and engineered articular
cartilage, but the mechanisms of mechanical signal transduction are not
fully understood. TRPV4 (Transient Receptor Potential Vanilloid 4) is
a Ca2+-permeable non-selective cation channel that functions in the
transduction of osmotic changes in chondrocytes. Cartilage loading
produces changes in local tissue osmolality due to ﬂuid exudation and
changes inﬁxed charge density. Therefore, TRPV4maybe involved in the
metabolic and functional response of articular cartilage to mechanical
stimulation. The goal of this study was to determine the role of TRPV4
activation in the response of chondrocyte-laden agarose constructs to
dynamic compressive loading (DL), as well as to determine if speciﬁc
chemical activation of TRPV4 enhances cartilage matrix biosynthesis.
Methods: Porcine chondrocytes were enzymatically isolated from
skeletally immature pigs (w30kg) and mixed with agarose to form
chondrocyte-laden disks (2% agarose, 4mm diameter x 2.25mm thick,
10M cells/mL). Constructswere cultured in 10% FBS containingmedia for
2 weeks, following which disks were loaded between impermeable
platens in unconﬁned compression (10% peak-to-peak strain, 7% offset,
1.0Hz sine wave, 3 hrs/day, 5 days/wk for 4 wks), or left in free swelling
conditions. To better understand the role of TRPV4-mediated signaling
during DL, GSK205, a speciﬁc TRPV4 antagonist, or vehicle control (0.1%
DMSO), was added prior to and washed off immediately after loading
(n¼3-4). To determine the response of chondrocytes to selective
chemical activation of TRPV4, day 3 constructs (20M cells/mL) were
pulsedwith GSK101, a potent and speciﬁc TRPV4 agonist, or with vehicle
control (0.1% DMSO), for 1 hr/day, 5 days/wk, for 4 wks (n¼6-8).
Constructs were evaluated for sulfated glycosaminoglycan (s-GAG) and
collagen content using the DMMB and OHP assays. To evaluate construct
functional properties, disks were mechanically tested in unconﬁned
compression between impermeable platens in PBS. After the application
of a small (1.3gf) tare load for 5 min, constructs were equilibrated under
a 10% strain for 20min, fromwhich the Young'smodulus was calculated.
The dynamicmoduluswasmeasured by superimposing a 0.1Hz 2% peak-to-peak sine wave upon this 10% strain, and dividing the amplitude of
the resulting stress wave by the applied strain. One-way ANOVA was
performed followed by Fisher's LSD post-hoc analysis.
Results: DL increased both biochemical measures and the dynamic
modulus of the constructs. Daily exposure to GSK205 alone had little
effect on construct bulk biochemical content and functional properties.
Underdynamic loadingconditions,GSK205blocked thedynamic loading-
induced increase in GAG and collagen content, and reduced both the
Young's modulus and dynamic modulus compared to DL disks without
GSK205. In unloaded constructs, daily chemical activation of TRPV4 with
GSK101 signiﬁcantly increased total s-GAG and collagen contents, as well
as enhanced the Young's and dynamic moduli of the constructs.
Conclusions: These ﬁndings suggest that the biosynthetic response of
chondrocytes to dynamic compressive loading is mediated by TRPV4.
Inhibition of TRPV4 with GSK205 largely blocked the anabolic response
of chondrocyte-laden constructs to dynamic loading. Furthermore,
periodic selective chemical activation of TRPV4 increasedmatrix content
and functional properties of constructs in a similar manner to what was
observed with dynamic loading. An improved understanding of TRPV4
in chondrocytemechanotransductionmay provide new insights into the
development of novel therapies for osteoarthritis as well as the
enhancement of tissue-engineering approaches for cartilage repair.
